IVCC
The IVCC is a Product Development Partnership (PDP) established as a not for profit company and registered charity to overcome the barriers to innovation in the development of new insecticides for public health vector control and to develop information systems and tools which will enable new and existing pesticides to be used more effectively.
Financial health, per its FY2025 accounts
The accounts state that the charity generated a surplus of £1.8m for the year ended 31 July 2025, resulting in total free/unrestricted reserves of £13.0m. The trustees confirm that the charity has adequate resources to continue in operation for the foreseeable future, citing a positive bank balance of £9.1m and significant deferred income. The financial position is supported by a strong asset base and medium-term funding visibility from major donors.
What the accounts disclose
“FCDO accounted for 54% of the charity’s income in the year, up from 33% in 2024.” — page 12
“IVCC aligns with the group policy of ensuring that unrestricted reserves represent a minimum of 6 months' pay expenditure (£1.6m).” — page 13
“During 2025, charitable research grants totalling £1,899,000 (2024: £2,180,000) were passed to IVCC’s parent company Liverpool School of Tropical Medicine (LSTM); all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £3,444,000 (2024: £1,218,000) were passed to IVCC’s sister company iiDiagnostics ; all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £1,899,000 (2024: £2,180,000) were passed to IVCC’s parent company Liverpool School of Tropical Medicine (LSTM); all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £3,444,000 (2024: £1,218,000) were passed to IVCC’s sister company iiDiagnostics ; all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £1,899,000 (2024: £2,180,000) were passed to IVCC’s parent company Liverpool School of Tropical Medicine (LSTM); all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £3,444,000 (2024: £1,218,000) were passed to IVCC’s sister company iiDiagnostics ; all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £1,899,000 (2024: £2,180,000) were passed to IVCC’s parent company Liverpool School of Tropical Medicine (LSTM); all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £3,444,000 (2024: £1,218,000) were passed to IVCC’s sister company iiDiagnostics ; all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £1,899,000 (2024: £2,180,000) were passed to IVCC’s parent company Liverpool School of Tropical Medicine (LSTM); all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £3,444,000 (2024: £1,218,000) were passed to IVCC’s sister company iiDiagnostics ; all had performance conditions attached.” — page 31
Leadership, per the charity’s website
- Justin McBeath — Chief Executive Officer
- Chris Larkin — Director
- Mathias Mondy — Director
- Dr Derric Nimmo — Director
- Leo Smedley — Director
- David Worrall — Director
Funders the charity credits
- Global Fund
- Unitaid
- USAID
Structured financials (annual return, FY ending 31/07/2025)
Trustees
- Sherwin Charleschair
- Alan Court
- Dr Bruno Suzette Roger Moonen
- Dr Elizabeth Chizema
- Dr Jacqueline Applegate
- Jonathan Schofield
- Ray Nishimoto
- Susan Russell
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/07/2025 | £19.1m | £17.3m |
| 31/07/2024 | £20.3m | £20.2m |
| 31/07/2023 | £33.4m | £32.3m |
| 31/07/2022 | £48.6m | £47.5m |
| 31/07/2021 | £39.4m | £38.2m |
Common questions
Is IVCC financially healthy?
Per its FY2025 accounts: The accounts state that the charity generated a surplus of £1.8m for the year ended 31 July 2025, resulting in total free/unrestricted reserves of £13.0m. The trustees confirm that the charity has adequate resources to continue in operation for the foreseeable future, citing a positive bank balance of £9.1m and significant deferred income. The financial position is supported by a strong asset base and medium-term funding visibility from major donors. Its FY2025 accounts were audited by Crowe U.K. LLP.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE MASTER CHARITABLE TRUST | 1 | £850k |
| THE BURDETT TRUST FOR NURSING | 1 | £262k |
| THE PEARS FAMILY CHARITABLE FOUNDATION | 1 | £151k |
| THE AIM FOUNDATION | 1 | £125k |
| JOFFE CHARITABLE TRUST CIO | 1 | £95k |
| THE BILLMEIR CHARITABLE TRUST | 1 | £50k |
| THE NUTRITIONAL WELLBEING FOUNDATION | 1 | £40k |
| THE KPMG FOUNDATION | 1 | £25k |
Charities like this
- INSTITUTE FOR VOLUNTARY ACTION RESEARCH
- THE INTERNATIONAL INSTITUTE FOR CONSERVATION OF HISTORIC AND ARTISTIC WORKS
- INFECTION PREVENTION SOCIETY
- THE INSTITUTE FOR CANCER VACCINES AND IMMUNOTHERAPY
- INSTITUTE OF HEALTH VISITING
- THE ICKLE PICKLE PARTNERSHIP LTD
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| IVCC | £19.1m | — | — | unclear | — | no doubt |
| INSTITUTE FOR VOLUNTARY ACTION RESEARCH | £1.0m | — | — | unclear | — | no doubt |
| THE INTERNATIONAL INSTITUTE FOR CONSERVATION OF HISTORIC AND ARTISTIC WORKS | £435k | £60,000 - £69,000 | 1 | above | — | no doubt |
| INFECTION PREVENTION SOCIETY | £825k | — | 0 | above | — | no doubt |
| THE INSTITUTE FOR CANCER VACCINES AND IMMUNOTHERAPY | £433k | £70,001 - £80,000 | 1 | unclear | 6.0% | no doubt |
| INSTITUTE OF HEALTH VISITING | £1.7m | £70,001 - £80,000 | 2 | unclear | — | no doubt |